
A recent study evaluated the effectiveness of tenecteplase (TNK) compared to alteplase (ALT) in acute ischemic stroke patients undergoing mechanical thrombectomy. The meta-analysis included ten studies with 3722 patients. TNK showed superior early recanalization rates over ALT without increasing the risk of intracerebral hemorrhage. Functional independence at 90 days was similar between TNK and ALT patients, but TNK was associated with lower mortality within 90 days. These findings highlight TNK's benefits in achieving early recanalization and reducing mortality in acute ischemic stroke patients undergoing mechanical thrombectomy. The study's results provide valuable insights for improving treatment outcomes in this patient population.
Like
Save
Share